Skip to main content

Table 1 Baseline characteristics for patients with UA levels above and below median and all patients

From: Uric acid: association with rate of renal function decline and time until start of dialysis in incident pre-dialysis patients

 

UA ≤ 7.9 mg/dl

UA > 7.9 mg/dl

Total

(median)

(median)

(n = 131)

 

(n = 70)

(n = 61)

 

UA (mg/dl) (sd)

6.69 (0.89)

9.5 (1.32)

8.0 (1.79)

Age (years) (sd)

64.0 (14.0)

63.2 (15.4)

63.6 (14.6)

Sex (% male)

62.9

75.4

68.7

Ethnicity (% caucasian)

94.3

98.4

96.2

Diabetes (%)

20.0

19.7

19.8

PKD

   

% Diabetes

7.1

9.8

8.4

% Glomerulonephritis

12.9

13.1

13.0

% Renal vascular disease

27.1

34.4

30.5

% Other

52.9

42.6

48.1

Hypertension* (%)

74.3

83.6

78.6

BMI (kg/m2) (sd)

26.3 (4.8)

25.0 (3.9)

25.7 (4.4)

CVD (%)

35.7

44.3

39.7

eGFR (MDRD)** (sd)

16.9 (5.7)

16.4 (5.7)

16.8 (5.7)

SBP (mm Hg) (sd)

143.9 (21.6)

141.4 (17.9)

142.7 (19.9)

DBP (mm Hg) (sd)

78.8 (12.3)

78.7 (10.9)

78.8 (11.6)

Total cholesterol (mmol/L) (sd)

4.33 (0.95)

4.48 (1.0)

4.42 (0.98)

LDL (mmol/L) (sd)

2.37 (0.78)

2.52 (0.95)

2.47 (0.87)

Proteinuria*** (%)

85.7

66.7

67.7

Diuretics (%)

44.1

55.7

50.4

Protein-restricted diet (%)

73.1

80.3

76.9

Allopurinol (%)

29.4

4.9

18.2

  1. PKD = Primary kidney disease, BMI = Body Mass Index, CVD = Cardiovascular disease, SBP = systolic blood pressure, DBP = diastolic blood pressure, LDL = low-density lipoprotein.
  2. *As diagnosed by a physician.
  3. **in ml/min/1.73 m3.
  4. ***defined as >300 mg/day in urine.